Literature DB >> 25747780

First case of NDM-1 producing Klebsiella pneumoniae in Caribbean islands.

Sylvaine Bastian1, Patrice Nordmann2, Elodie Creton3, Edith Malpote4, Guillaume Thiery5, Frederic Martino4, Sebastien Breurec5, Laurent Dortet6.   

Abstract

OBJECTIVES: Characterize a NDM-1 producing K. pneumoniae isolate recovered from a patient hospitalized in Guadeloupe, French West Indies, after its transfer from Cuba
METHODS: Antibiotic susceptibilities were determined by the disk diffusion method, and E-test. Carbapenemase production was assessed using the Carba NP test. Antibiotic resistance determinants and their surrounding structures were characterized by PCR mapping and DNA sequencing. Transfer of the β-lactam resistance marker was attempted by liquid mating-out assays
RESULTS: Here we reported the first NDM-1 producing enterobacterial isolate recovered from Caribbean islands. This K. pneumoniae isolate belongs to a new sequence type (ST1649). The blaNDM-1 gene together with the aacA4 gene were carried on a self conjugative IncR plasmid of c.a. 80kb.
CONCLUSION: This study describes the first identification of a NDM-1 producer in Caribbean islands. The uncommon incompatibility group of the blaNDM-1 carrying plasmid and the uncommon ST type of the K. pneumoniae strain suggest a possible local emergence of NDM producers.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cuba; Guadeloupe; NDM-1; carbapenemase; metallo-β-lactamase

Mesh:

Substances:

Year:  2015        PMID: 25747780     DOI: 10.1016/j.ijid.2015.03.002

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  High Prevalence of bla CTXM-1/IncI1-Iγ/ST3 Plasmids in Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates Collected From Domestic Animals in Guadeloupe (French West Indies).

Authors:  Gaëlle Gruel; David Couvin; Stéphanie Guyomard-Rabenirina; Guillaume Arlet; Jean-Christophe Bambou; Matthieu Pot; Xavier Roy; Antoine Talarmin; Benoit Tressieres; Séverine Ferdinand; Sébastien Breurec
Journal:  Front Microbiol       Date:  2022-05-16       Impact factor: 6.064

2.  Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements.

Authors:  Chaitra Shankar; Purva Mathur; Manigandan Venkatesan; Agila Kumari Pragasam; Shalini Anandan; Surbhi Khurana; Balaji Veeraraghavan
Journal:  BMC Microbiol       Date:  2019-06-24       Impact factor: 3.605

3.  Caribbean multi-centre study of Klebsiella pneumoniae: whole-genome sequencing, antimicrobial resistance and virulence factors.

Authors:  Eva Heinz; Richard Brindle; Andrina Morgan-McCalla; Keisha Peters; Nicholas R Thomson
Journal:  Microb Genom       Date:  2019-04-29

4.  Dissemination of Extended-Spectrum-β-Lactamase-Producing Enterobacter cloacae Complex from a Hospital to the Nearby Environment in Guadeloupe (French West Indies): ST114 Lineage Coding for a Successful IncHI2/ST1 Plasmid.

Authors:  Matthieu Pot; Stéphanie Guyomard-Rabenirina; David Couvin; Célia Ducat; Vincent Enouf; Séverine Ferdinand; Gaëlle Gruel; Edith Malpote; Antoine Talarmin; Sébastien Breurec; Yann Reynaud
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

5.  Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.

Authors:  Stéphanie Guyomard-Rabenirina; Joyce Malespine; Célia Ducat; Syndia Sadikalay; Mélanie Falord; Dorothée Harrois; Vincent Richard; Charles Dozois; Sébastien Breurec; Antoine Talarmin
Journal:  BMC Microbiol       Date:  2016-06-24       Impact factor: 3.605

6.  Clonal diversity and genetic profiling of antibiotic resistance among multidrug/carbapenem-resistant Klebsiella pneumoniae isolates from a tertiary care hospital in Saudi Arabia.

Authors:  Taher Uz Zaman; Maha Alrodayyan; Maha Albladi; Mohammed Aldrees; Mohammed Ismail Siddique; Sameera Aljohani; Hanan H Balkhy
Journal:  BMC Infect Dis       Date:  2018-05-03       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.